Zeo ScientifiX, Inc. filed a Form 8-K on November 3, 2026, announcing that its manufacturing facility became the first to achieve Quality Management Systems Certification under the newly established certification program of the Association for the Advancement of Blood & Biotherapies.

Key Highlights

  • First certified facility: According to the filing, Zeo ScientifiX's manufacturing facility is the first to achieve Quality Management Systems Certification under the Association for the Advancement of Blood & Biotherapies' newly established certification program.
  • Event date: The certification announcement was issued by the company on November 3, 2026, via press release.
  • Press release attached: A copy of the press release, dated November 3, 2026, is included as Exhibit 99.1 to the filing.
  • Signed by CEO/CFO: The filing was signed by Ian T. Bothwell, who serves as both Chief Executive Officer and Chief Financial Officer of Zeo ScientifiX, Inc.
  • Registrant details: Zeo ScientifiX, Inc. is a Nevada-incorporated company headquartered at 3321 College Avenue, Suite 246, Davie, Florida 33314, with no securities registered under Section 12(b) of the Act.

Zeo ScientifiX Reports First AABB Quality Management Systems Certification for Its Manufacturing Facility

According to the Form 8-K filed with the U.S. Securities and Exchange Commission on November 3, 2026, Zeo ScientifiX, Inc. disclosed that its manufacturing facility has become the first facility to achieve Quality Management Systems Certification under the newly established certification program of the Association for the Advancement of Blood & Biotherapies. The company disclosed this development through a press release issued on the same date, which is attached to the filing as Exhibit 99.1.

The filing was submitted under Item 8.01 (Other Events) of Form 8-K, indicating the company deemed the certification a reportable event. No financial statements or pro forma financial information were included with this filing. The registrant, incorporated in Nevada, lists no securities registered on a national exchange under Section 12(b) of the Act, with the trading symbol and exchange fields marked "N/A" on the filing's cover page.

Ian T. Bothwell, serving in the dual role of Chief Executive Officer and Chief Financial Officer, signed the filing on behalf of Zeo ScientifiX, Inc. The company's principal executive offices are located in Davie, Florida.

What Was Disclosed

Zeo ScientifiX, Inc. reported via an 8-K filed November 3, 2026, that its manufacturing facility is the first to receive Quality Management Systems Certification under the Association for the Advancement of Blood & Biotherapies' new certification program. A press release was attached as Exhibit 99.1.